Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses

Vaccine

Volumn 25, Issue 48, 2007, Pages 8133-8139

  Lee, Min Shi ^a   Chen, Meng Chun ^a   Liao, Yu Chieh ^a   Hsiung, Chao Agnes ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antigenicity; Bioinformatics; Hemagglutinin; Influenza vaccines

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; BIOINFORMATICS; CROSS REACTION; GENETIC DRIFT; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; MEDICAL INFORMATICS; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; VIRUS ISOLATION;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS;

EID: 35848970587     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.039     Document Type: Article

References (29)

1. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-6 (2007) 1-54
2. Klimov A., Simonsen L., Fukuda K., and Cox N. Surveillance and impact of influenza in the United States. Vaccine 17 Suppl 1 (1999) S42-S46
3. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2000-2001 season. Wkly Epidemiol Rec 75 (2001) 61-68
4. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
5. Wilson I.A., and Cox N. Structural Basis of Immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8 (1990) 737-771
6. Kilbourne E.D. Future influenza vaccines and the use of genetic recombinants. Bull WHO 41 (1969) 643-645
7. Bush R.M., Bender C.A., Subbarao K., Cox N.J., and Fitch W.M. Predicting the evolution of human influenza A. Science 286 (1999) 1921-1925
8. Macken C., Lu H., Goodman J., and Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus A.D.M.E., Cox N., and Hampson A.W. (Eds). Options for the control of influenza IV (2001), Elsevier Science, Amsterdam 103-106
9. Air G.M., and Laver W.G. Antigenic structure of influenza viruses. In: van Regenmortel M.H.V., and Neurath A.R. (Eds). Immunochemistry of viruses (1985), Elsevier, Oxford 213-238
10. Thomas D.B., Patera A.C., Graham C.M., and Smith C.A. Antibody-mediated immunity. In: Nicholson K.G., Hay A.J., and Webster R.G. (Eds). Textbook of influenza (1998), Blackwell Science Ltd., Oxford 267-277
11. Plotkin J.B., and Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci USA 100 (2003) 7152-7157
12. Lee M.S., and Chen J.S. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 10 (2004) 1385-1390
13. Wood J.M., Oxford J.S., Una D., Newman R.W., Major D., Robertson J.S., and Influenza A. (H1N1) Vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171 (1989) 214-221
14. Newman R.W., Jennings R., Major D.L., Robertson J.S., Jenkins R., Potter C.W., et al. Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule. Vaccine 11 (1993) 400-406
15. Katz J.M., and Webster R.G. Efficacy of inactivated influenza A Virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 160 (1989) 191-198
16. Kodihalli S., Justewicz D.M., Gubareva L.V., and Webster R.G. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J Virol 69 (1995) 4888-4897
17. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., et al. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336 (2005) 113-119
18. CDC (USA). Information for the Vaccines and Related Biological Products Advisory Committee, CBER, FDA. Atlanta, February 18-19, 2004. Available from http://www.fda.gov/ohrms/dockets/ac/04/briefing/.
19. WHO Collaborating Centre for Reference and Research on Influenza, Information for Australian Influenza Vaccine Committee Meeting. October 2004. Melbourne, Australia.
20. WHO Collaborating Centre for Reference and Research on Influenza, Information for Australian Influenza Vaccine Committee Meeting. October 2003. Melbourne, Australia.
21. Schild G.C., Henry-Aymard M., Pereira M.S., Chakraverty P., Dowdle W., Coleman M., and Chang W.K. Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ 48 (1973) 269-278
22. Smith D.J. Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. Vaccine 21 (2003) 1758-1761
23. Layne S.P. Human influenza surveillance: the demand to expand. Emerg Infect Dis 12 (2006) 562-568
24. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305 (2004) 371-376
25. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., and Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol 73 (1999) 9679-9682
26. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97 (2000) 6108-6113
27. Nolan T., Lee M.S., Cordova J.M., Cho I., Walker R.E., August M.J., Larson S., Coelingh K.L., and Mendelman P.M. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. Vaccine 21 (2003) 1224-1231
28. Lee M.S., and Yang C.F. Cross-reactive H1N1 antibody responses to a live-attenuated influenza vaccine in children: implication for selection of vaccine strains. J Infect Dis 188 (2003) 1362-1366
29. Shih A.C.C., Lee D.T., Peng C.L., and Wu Y.W. Phylo-mLogo: an interactive and hierarchical multiple-logo visualization tool for alignment of many sequences. BMC Bioinformat. 8 (2007) 63